Recent data indicates that retatrutide, a dual-action medication, may represent a major step in weight reduction . This drug combines the properties of a GLP-1 receptor and a GIP analog, seemingly offering a greater outcome than available approaches . Patient trials have revealed promising outcomes, including substantial reductions in body and impr